Alaunos Therapeutics analyst ratings
Alaunos Therapeutics analyst ratings
While ratings are subjective and will change, the latest Alaunos Therapeutics (TCRT) rating was a with a price target of $0.00 to $3.00. The current price Alaunos Therapeutics (TCRT) is trading at is $1.40, which is within the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 07/15/2022 | 114.29% | Cantor Fitzgerald | → $3 | Assumes | → Overweight |
| 05/04/2022 | 114.29% | Wells Fargo | → $3 | Upgrades | Equal-Weight → Overweight |
| 日期 | 上行/下行 | 分析公司 | 目标价格变动 | 评级变动 | 之前/当前的评级 |
|---|---|---|---|---|---|
| 07/15/2022 | 114.29% | 坎托·菲茨杰拉德 | → 3 美元 | 假设 | → 超重 |
| 05/04/2022 | 114.29% | 富国银行 | → 3 美元 | 升级 | 重量相等 → 超重 |
Alaunos Therapeutics Questions & Answers
Alaunos Therapeutics 问题与解答
The latest price target for Alaunos Therapeutics (NASDAQ: TCRT) was reported by Cantor Fitzgerald on July 15, 2022. The analyst firm set a price target for $3.00 expecting TCRT to rise to within 12 months (a possible 114.29% upside). 2 analyst firms have reported ratings in the last year.
坎托·菲茨杰拉德于2022年7月15日公布了Alaunos Therapeutics（纳斯达克股票代码：TCRT）的最新目标股价。该分析公司将目标股价定为3.00美元，预计TCRT将在12个月内升至12个月内（可能上涨114.29％）。去年有两家分析公司公布了评级。
The latest analyst rating for Alaunos Therapeutics (NASDAQ: TCRT) was provided by Cantor Fitzgerald, and Alaunos Therapeutics their overweight rating.
坎托·菲茨杰拉德对Alaunos Therapeutics（纳斯达克股票代码：TCRT）的最新分析师评级由坎托·菲茨杰拉德提供，而Alaunos Therapeutics则提供了增持评级。
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Alaunos Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Alaunos Therapeutics was filed on July 15, 2022 so you should expect the next rating to be made available sometime around July 15, 2023.
分析师在进行了广泛的研究后得出了股票评级，其中包括浏览公开财务报表，与Alaunos Therapeutics的高管和客户交谈，以及听取财报电话会议。大多数分析师每三个月做一次这样的评级，因此每家公司每年应该获得4次评级。Alaunos Therapeutics的最新评级是在2022年7月15日公布的，因此您应该预计下一个评级将在2023年7月15日左右公布。
While ratings are subjective and will change, the latest Alaunos Therapeutics (TCRT) rating was a with a price target of $0.00 to $3.00. The current price Alaunos Therapeutics (TCRT) is trading at is $1.40, which is within the analyst's predicted range.
尽管评级是主观的，并且会发生变化，但最新的Alaunos Therapeutics（TCRT）评级为A，目标股价为0.00美元至3.00美元。Alaunos Therapeutics（TCRT）目前的交易价格为1.40美元，在分析师的预测区间内。
